GO:0010657 muscle cell apoptotic process: Regulated Cell Death Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0010657 (muscle cell apoptotic process) describes the programmed death of mature contractile muscle cells (myocytes) through caspase-dependent dismantling.
• It is a biological_process that is distinct from generic apoptosis because it occurs in the specialized context of vascular, skeletal, cardiac, and airway smooth muscle cells [1,2].
• Dysregulated muscle cell apoptosis contributes to aortic dissection, abdominal aortic aneurysm, atherosclerosis, pulmonary hypertension, and skeletal muscle dysfunction [2,3,4,5,6].
• Key molecular players include caspases, ATF3, TRIB2, MAP2K6/p38, miR-145-5p, miR-140-3p, EDIL3/Del-1, and dystrophin [2,3,5,6,7,8].
• Efferocytosis of apoptotic vascular smooth muscle cells is a critical clearance step whose failure worsens vascular disease [2,4].
• CRISPR knockout, point-mutation, knock-in, and overexpression models are essential to establish causality for candidate genes in muscle cell apoptotic process [1,3,5].
Description
GO:0010657, muscle cell apoptotic process, is the biological process by which a mature contractile muscle cell, or myocyte, is dismantled and killed through the activity of proteolytic caspases following external or internal death signals. This term captures a specialized form of programmed cell death that occurs in the three main muscle types: vascular smooth muscle, skeletal muscle, and cardiac muscle [1,6]. Unlike generic apoptosis, muscle cell apoptotic process is defined by the unique structural and functional context of the myocyte, including its contractile apparatus and its role in tissue mechanics [1,8]. Researchers study this process because loss of muscle cells is a central pathological event in cardiovascular and musculoskeletal disease [1,2]. In vascular disease, regulated death of vascular smooth muscle cells contributes to aortic dissection, abdominal aortic aneurysm, and atherosclerosis [2,3,4]. In skeletal muscle, apoptotic signaling is linked to muscle dysfunction and atrophy. In pulmonary hypertension, apoptosis and proliferation of pulmonary artery smooth muscle cells are tightly balanced by signaling pathways such as TRIB2/SERCA2 and miR-140-3p/MAP2K6/p38 [5,7]. Understanding GO:0010657 therefore requires integrating death-receptor signaling, mitochondrial stress, caspase activation, and clearance of dying cells by efferocytosis [1,2,4].
muscle cell apoptotic process At A Glance
| GO ID | GO:0010657 |
|---|---|
| GO term | muscle cell apoptotic process |
| Ontology | biological_process |
| Synonym | muscle cell apoptosis |
| Definition | A form of programmed cell death induced by external or internal signals that trigger the activity of proteolytic caspases, whose actions dismantle a muscle cell and result in its death. A muscle cell is a mature contractile cell, commonly known as a myocyte, that forms one of three kinds of muscle. |
| Major function | Execution of caspase-dependent programmed death in mature contractile muscle cells |
| Cell types involved | Vascular smooth muscle cells, skeletal muscle myotubes, cardiac myocytes, airway smooth muscle cells |
| Disease relevance | Aortic dissection, abdominal aortic aneurysm, atherosclerosis, pulmonary hypertension, skeletal muscle dysfunction |
What Is GO:0010657?
In our own words, GO:0010657 describes the ordered, caspase-driven death of a muscle cell after it receives external or internal signals. The process dismantles the contractile myocyte and ends in its death, and it is classified as a biological_process in the Gene Ontology. The official synonym is muscle cell apoptosis.
Why Is muscle cell apoptotic process Important in Cell Biology?
GO:0010657 is important because the regulated death of muscle cells is a decisive event in common and life-threatening human diseases. In the vessel wall, apoptosis of vascular smooth muscle cells destabilizes the aorta and contributes to dissection and aneurysm, while impaired clearance of apoptotic cells by efferocytosis amplifies inflammation [2,3,4]. In the lung circulation, an imbalance between apoptosis and proliferation of pulmonary artery smooth muscle cells drives pulmonary hypertension [5,7]. In skeletal muscle, apoptotic signaling is associated with muscle dysfunction and loss of contractile capacity. Because muscle cells are post-mitotic and structurally specialized, their death cannot be easily replaced, making the pathways that control GO:0010657 attractive targets for mechanistic studies and therapeutic hypotheses [1,8].
• Muscle cell apoptotic process is a core mechanism of vascular smooth muscle cell loss in aortic dissection and aneurysm [2,3].
• Apoptotic vascular smooth muscle cells that are not efficiently cleared by efferocytosis promote atherosclerosis progression.
• Pulmonary artery smooth muscle cell apoptosis and proliferation are balanced by pathways such as TRIB2/SERCA2 and miR-140-3p/MAP2K6/p38 in pulmonary hypertension [5,7].
• Skeletal muscle apoptotic signaling is linked to muscle dysfunction and myotube death.
• Dystrophin deficiency alters vascular smooth muscle cell biology, connecting muscular dystrophy to vascular phenotypes.
• Caspases are the central proteolytic executors of muscle cell apoptotic process.
• ATF3 expression dynamics determine vascular smooth muscle cell fate in abdominal aortic aneurysm.
• EDIL3/Del-1 enhances internalization and degradation of apoptotic vascular smooth muscle cells, protecting against aortic dissection.
• miR-145-5p elevation is associated with skeletal muscle dysfunction and triggers apoptotic cell death in C2C12 myotubes.
• Understanding GO:0010657 supports development of experimental models for cardiovascular and musculoskeletal disease research [1,5].
What Happens During muscle cell apoptotic process?
Initiation by external or internal death signals
In simple terms: The muscle cell receives a death signal from outside or inside itself.
Muscle cell apoptotic process begins when external or internal signals trigger the death program in a mature contractile myocyte. In vascular smooth muscle cells, regulated death can be initiated by environmental stressors and inflammatory cues that are relevant to vascular disease [1,3]. In skeletal muscle, elevated miR-145-5p is associated with dysfunction and triggers apoptotic cell death in C2C12 myotubes, illustrating how a microRNA can initiate the process. In pulmonary artery smooth muscle cells, signaling through MAP2K6/p38 and TRIB2/SERCA2 influences cell fate and survival decisions [5,7].
Caspase activation and proteolytic dismantling
In simple terms: Caspases, the cell's executioner enzymes, become active and break down the muscle cell.
The defining feature of GO:0010657 is the activity of proteolytic caspases, whose actions dismantle the muscle cell and result in its death. This caspase-dependent execution distinguishes muscle cell apoptotic process from other forms of cell death and is the mechanistic core of the GO term. Because muscle cells are large, specialized contractile cells, caspase-mediated dismantling affects the contractile apparatus and the structural integrity of the myocyte [1,8].
Cell fate decisions in vascular smooth muscle
In simple terms: Proteins such as ATF3 help decide whether a smooth muscle cell lives or dies.
Spatiotemporal ATF3 expression determines vascular smooth muscle cell fate in abdominal aortic aneurysm, linking a stress-responsive transcription factor to the life-or-death decision that underlies muscle cell apoptotic process. This illustrates that GO:0010657 is not a passive event but is actively regulated by intracellular signaling programs. Similarly, TRIB2 promotes pulmonary artery smooth muscle cell proliferation through SERCA2 ubiquitination, showing how proliferation and death pathways are balanced in smooth muscle.
Clearance of apoptotic muscle cells by efferocytosis
In simple terms: After the muscle cell dies, other cells must clean it up.
EDIL3/Del-1 prevents aortic dissection through enhancing internalization and degradation of apoptotic vascular smooth muscle cells, demonstrating that clearance of dying muscle cells is a protective step. Conversely, an oral pathogen aggravates atherosclerosis by inducing smooth muscle cell apoptosis and repressing macrophage efferocytosis, showing that failed clearance worsens disease. Thus, GO:0010657 is functionally coupled to efferocytosis in the vessel wall [2,4].
Consequences for tissue structure and function
In simple terms: Losing muscle cells weakens the tissue they support.
Because muscle cells provide contractile and structural support, their apoptotic loss has direct tissue consequences. In the aorta, loss of vascular smooth muscle cells contributes to dissection and aneurysm [2,3]. In skeletal muscle, apoptotic cell death in myotubes is associated with muscle dysfunction. In the pulmonary circulation, altered smooth muscle cell survival contributes to pulmonary hypertension [5,7]. Dystrophin deficiency further impacts vascular smooth muscle cell biology, connecting muscle structural proteins to vascular cell behavior.
Key Genes Involved in GO:0010657 muscle cell apoptotic process
The following genes and non-coding regulators have been experimentally linked to muscle cell apoptotic process and related smooth or skeletal muscle cell fate decisions in the cited literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| CASP family (caspases) | Proteolytic execution of apoptosis | Central effectors of GO:0010657 |
| ATF3 | Stress-responsive transcription factor controlling VSMC fate | Determines VSMC fate in abdominal aortic aneurysm |
| TRIB2 | Promotes pulmonary artery smooth muscle cell proliferation via SERCA2 ubiquitination | Pulmonary hypertension mechanism |
| SERCA2 (ATP2A2) | Calcium pump targeted by TRIB2 ubiquitination | Smooth muscle proliferation and survival |
| MAP2K6 | Kinase in the p38 pathway | Mediates miR-140-3p effects on PASMC dysfunction |
| p38 (MAPK14) | Stress-activated MAP kinase | Downstream of MAP2K6 in PASMC dysfunction |
| miR-145-5p | MicroRNA associated with skeletal muscle dysfunction | Triggers apoptotic cell death in C2C12 myotubes |
| miR-140-3p | MicroRNA alleviating PASMC dysfunction | Acts via MAP2K6/p38 pathway |
| EDIL3/Del-1 | Enhances internalization and degradation of apoptotic VSMCs | Protects against aortic dissection |
| Dystrophin (DMD) | Muscle structural protein | Dystrophin deficiency impacts vascular smooth muscle cells |
| Efferocytosis machinery (macrophage) | Clearance of apoptotic cells | Repressed by oral pathogen in atherosclerosis |
| Vascular smooth muscle cell regulators | Control of regulated cell death | Reviewed in vascular disease context |
How Is muscle cell apoptotic process Regulated?
Muscle cell apoptotic process is regulated at multiple levels. Spatiotemporal expression of the transcription factor ATF3 determines vascular smooth muscle cell fate in abdominal aortic aneurysm, showing transcriptional control of the life-or-death decision. In pulmonary artery smooth muscle cells, TRIB2 promotes proliferation through SERCA2 ubiquitination, indicating that ubiquitin-dependent regulation of calcium handling influences smooth muscle cell survival. The miR-140-3p/MAP2K6/p38 pathway alleviates pulmonary arterial smooth muscle cell dysfunction, demonstrating microRNA and kinase regulation of the process. Elevated miR-145-5p is associated with skeletal muscle dysfunction and triggers apoptotic cell death in C2C12 myotubes, adding another layer of post-transcriptional control. Finally, EDIL3/Del-1-dependent internalization and degradation of apoptotic vascular smooth muscle cells shows that clearance mechanisms regulate the net outcome of muscle cell apoptosis in tissue.
muscle cell apoptotic process and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| EDIL3/Del-1 | Aortic dissection; clearance of apoptotic VSMCs | Knockout and overexpression in vascular smooth muscle cells |
| ATF3 | Abdominal aortic aneurysm; VSMC fate | Conditional knockout and tagged knock-in in VSMC |
| TRIB2 | Pulmonary hypertension; PASMC proliferation | Overexpression and point-mutation models in PASMC |
| miR-145-5p | Skeletal muscle dysfunction; myotube apoptosis | Overexpression and inhibition in C2C12 myotubes |
| Dystrophin (DMD) | Dystrophin deficiency; vascular smooth muscle cell biology | Knockout models in vascular smooth muscle cells |
Aortic dissection and abdominal aortic aneurysm
Regulated death of vascular smooth muscle cells is a key event in aortic disease. EDIL3/Del-1 prevents aortic dissection by enhancing internalization and degradation of apoptotic vascular smooth muscle cells, linking defective clearance of dying muscle cells to aortic wall failure. Spatiotemporal ATF3 expression determines vascular smooth muscle cell fate in abdominal aortic aneurysm, showing that transcriptional control of muscle cell apoptotic process influences aneurysm formation.
Atherosclerosis
An oral pathogen aggravates atherosclerosis by inducing smooth muscle cell apoptosis and repressing macrophage efferocytosis, demonstrating that both the death of muscle cells and the failure to clear them contribute to atherosclerotic disease. This connects GO:0010657 directly to inflammatory vascular pathology.
Pulmonary hypertension
In pulmonary hypertension, TRIB2 promotes pulmonary artery smooth muscle cell proliferation through SERCA2 ubiquitination, while miR-140-3p alleviates pulmonary arterial smooth muscle cell dysfunction via the MAP2K6/p38 pathway [5,7]. These findings show that the balance between survival, proliferation, and death of smooth muscle cells is central to pulmonary vascular disease [5,7].
Skeletal muscle dysfunction and dystrophin deficiency
Elevated miR-145-5p is associated with skeletal muscle dysfunction and triggers apoptotic cell death in C2C12 myotubes, directly linking GO:0010657 to skeletal muscle pathology. Dystrophin deficiency impacts vascular smooth muscle cell biology, connecting muscular dystrophy-related proteins to smooth muscle cell behavior.
From muscle cell apoptotic process-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is a candidate gene required for muscle cell apoptotic process? | CRISPR knockout in vascular or skeletal muscle cells [1,3] |
| Does a specific point mutation alter caspase-dependent death? | Point-mutation knock-in in myocytes [1,5] |
| Does a disease-associated variant change muscle cell fate? | Knock-in of the variant with functional apoptosis assays |
| Where and when is the protein expressed during apoptosis? | Tagged knock-in for imaging and localization |
| Does increased expression of a gene drive muscle cell death? | Overexpression in C2C12 myotubes or smooth muscle cells |
| Does a microRNA regulate muscle cell apoptotic process? | Overexpression and inhibition in myotubes [6,7] |
How to Study the muscle cell apoptotic process Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Caspase activity assay | Caspase enzymatic activity | Confirming execution of muscle cell apoptotic process |
| Annexin V / flow cytometry | Phosphatidylserine exposure | Quantifying apoptotic muscle cells [1,6] |
| RNA-seq | Transcriptome changes | Identifying regulators such as ATF3 |
| microRNA profiling | MicroRNA expression changes | Linking miR-145-5p and miR-140-3p to muscle cell death [6,7] |
| Ubiquitination assay | Protein ubiquitination status | Studying TRIB2-mediated SERCA2 regulation |
| Efferocytosis assay | Internalization and degradation of apoptotic cells | Testing EDIL3/Del-1 function [2,4] |
| Immunofluorescence imaging | Protein localization and cell morphology | Visualizing muscle cell dismantling [3,8] |
| Western blot | Protein cleavage and expression | Detecting caspase substrates and signaling changes [5,7] |
Apoptosis assays in muscle cells
Caspase activity assays, Annexin V staining, and DNA fragmentation assays are used to measure muscle cell apoptotic process directly, because the GO term is defined by caspase activity and cell death. These assays are applied to vascular smooth muscle cells, pulmonary artery smooth muscle cells, and C2C12 myotubes depending on the disease context [5,6].
Transcriptional and microRNA profiling
RNA-seq and microRNA profiling identify regulators such as ATF3, miR-145-5p, and miR-140-3p that control muscle cell fate and apoptosis [3,6,7]. Spatiotemporal expression analysis of ATF3 in abdominal aortic aneurysm illustrates how transcriptional profiling can reveal cell fate determinants.
Protein interaction and ubiquitination studies
Because TRIB2 promotes pulmonary artery smooth muscle cell proliferation through SERCA2 ubiquitination, ubiquitination and protein interaction assays are used to dissect post-translational regulation of smooth muscle cell survival. Such studies help define how signaling pathways feed into muscle cell apoptotic process.
Efferocytosis and clearance assays
Efferocytosis assays measure the internalization and degradation of apoptotic vascular smooth muscle cells, as shown for EDIL3/Del-1 in aortic dissection and for pathogen-repressed macrophage efferocytosis in atherosclerosis [2,4]. These methods connect the death of muscle cells to tissue-level outcomes [2,4].
How CRISPR Can Be Used to Study GO:0010657 muscle cell apoptotic process
Knockout
CRISPR knockout of candidate genes such as ATF3, TRIB2, or EDIL3/Del-1 allows researchers to test whether the gene is required for muscle cell apoptotic process or for protective clearance of apoptotic muscle cells [2,3,5]. Knockout models in vascular smooth muscle cells and myotubes provide causal evidence that complements observational disease data [1,3].
Point Mutation
Point-mutation models can be used to test whether specific residues or disease-associated variants alter caspase-dependent death or signaling in muscle cells [1,5]. For example, mutations affecting TRIB2-SERCA2 regulation can be introduced to dissect ubiquitination-dependent control of smooth muscle cell survival.
Knock-in
Knock-in of disease-associated variants or tagged alleles enables precise study of gene function in the context of muscle cell apoptotic process. Tagged knock-in of ATF3, for instance, supports spatiotemporal analysis of its expression during vascular smooth muscle cell fate decisions.
Overexpression
Overexpression of genes or microRNAs such as miR-145-5p in C2C12 myotubes can trigger apoptotic cell death, providing a gain-of-function complement to knockout studies. Overexpression of protective factors such as EDIL3/Del-1 can test whether enhanced clearance of apoptotic muscle cells prevents disease phenotypes.
How EDITGENE Supports muscle cell apoptotic process Research
Researchers studying muscle cell apoptotic process-related genes often need to determine whether a candidate gene is causally involved in caspase-dependent death of myocytes, or whether it merely correlates with disease. Establishing causality requires controlled genetic models in relevant muscle cell types, such as vascular smooth muscle cells, pulmonary artery smooth muscle cells, and skeletal myotubes [1,3,5,6]. EDITGENE provides the CRISPR and cell-model services needed to build those models and to interpret the resulting phenotypes in the context of GO:0010657.
Contact EDITGENE today to design your custom CRISPR model for muscle cell apoptotic process research.
Frequently Asked Questions About muscle cell apoptotic process
What is GO:0010657 muscle cell apoptotic process?
GO:0010657 is the biological process in which external or internal signals trigger caspase activity that dismantles a mature contractile muscle cell and causes its death.
What genes are involved in muscle cell apoptotic process?
Genes and regulators linked to this process include caspases, ATF3, TRIB2, SERCA2, MAP2K6, p38, miR-145-5p, miR-140-3p, EDIL3/Del-1, and dystrophin [1,2,3,5,6,7,8].
How is muscle cell apoptotic process different from general apoptosis?
It is a specialized form of programmed cell death that occurs in mature contractile myocytes and is defined by caspase-dependent dismantling of the muscle cell.
Which diseases involve muscle cell apoptotic process?
It is implicated in aortic dissection, abdominal aortic aneurysm, atherosclerosis, pulmonary hypertension, and skeletal muscle dysfunction [2,3,4,5,6].
What role does ATF3 play in muscle cell apoptotic process?
Spatiotemporal ATF3 expression determines vascular smooth muscle cell fate in abdominal aortic aneurysm, linking it to life-or-death decisions in muscle cells.
How does EDIL3/Del-1 affect apoptotic muscle cells?
EDIL3/Del-1 prevents aortic dissection by enhancing internalization and degradation of apoptotic vascular smooth muscle cells.
Can microRNAs regulate muscle cell apoptotic process?
Yes, elevated miR-145-5p triggers apoptotic cell death in C2C12 myotubes, and miR-140-3p alleviates pulmonary arterial smooth muscle cell dysfunction via MAP2K6/p38 [6,7].
What experimental models are used to study muscle cell apoptotic process?
Vascular smooth muscle cells, pulmonary artery smooth muscle cells, and C2C12 myotubes are used with caspase assays, RNA-seq, ubiquitination assays, and efferocytosis assays [1,2,5,6].
How does TRIB2 influence smooth muscle cell fate?
TRIB2 promotes pulmonary artery smooth muscle cell proliferation through SERCA2 ubiquitination in pulmonary hypertension.
Why is clearance of apoptotic muscle cells important?
Failed efferocytosis of apoptotic smooth muscle cells worsens atherosclerosis, while enhanced clearance by EDIL3/Del-1 protects against aortic dissection [2,4].
Conclusion
GO:0010657, muscle cell apoptotic process, defines the caspase-dependent death of mature contractile myocytes and is a central mechanism in vascular, pulmonary, and skeletal muscle disease [1,2,3,4,5,6]. The literature shows that this process is actively regulated by transcription factors, microRNAs, kinases, and ubiquitination pathways, and that clearance of dying muscle cells is as important as the death event itself [2,3,5,6,7]. Studying GO:0010657 with rigorous genetic models will continue to clarify how muscle cell fate decisions can be therapeutically modulated.
References
- 1. Yin Z et al.. 2024. Regulated vascular smooth muscle cell death in vascular diseases.. Cell Prolif 57(11):e13688 PMID: 38873710
- 2. Yin Z et al.. 2024. EDIL3/Del-1 prevents aortic dissection through enhancing internalization and degradation of apoptotic vascular smooth muscle cells.. Autophagy 20(11):2405-2425 PMID: 38873925
- 3. Wen Y et al.. 2024. Spatiotemporal ATF3 Expression Determines VSMC Fate in Abdominal Aortic Aneurysm.. Circ Res 134(11):1495-1511 PMID: 38686580
- 4. Xie H et al.. 2023. Oral pathogen aggravates atherosclerosis by inducing smooth muscle cell apoptosis and repressing macrophage efferocytosis.. Int J Oral Sci 15(1):26 PMID: 37380627
- 5. Zhang W et al.. 2026. TRIB2 promotes pulmonary artery smooth muscle cell proliferation through SERCA2 ubiquitination in pulmonary hypertension.. Free Radic Biol Med 243:414-433 PMID: 41213438
- 6. Jin J et al.. 2022. Elevated mir-145-5p is associated with skeletal muscle dysfunction and triggers apoptotic cell death in C2C12 myotubes.. J Muscle Res Cell Motil 43(3):135-145 PMID: 35753017
- 7. Chen L et al.. 2025. miR-140-3p Alleviates Pulmonary Arterial Smooth Muscle Cell Dysfunction via MAP2K6/p38 Pathway.. J Biochem Mol Toxicol 39(10):e70532 PMID: 40985983
- 8. Xuan W et al.. 2025. Impact of dystrophin deficiency on vascular smooth muscle cell.. Sci Rep 15(1):45254 PMID: 41286488
